We evaluated a simplified method for preparation and analysis of platelet cytochrome c oxidase activity in Alzheimer9s disease (AD) and control patients. Mean cytochrome c oxidase activity in controls (n = 17) was 0.233 sec−1/mg whereas mean cytochrome c oxidase activity in Alzheimer patients (n = 19) was 0.193 sec−1/mg, p=0.033. Complex III (ubiquinol:cytochrome c oxidoreductase), complex II (succinic dehydrogenase), and citrate synthase were all assayed as internal controls and were not significantly different in controls and Alzheimer patients. There is a relatively specific loss of platelet cytochrome c oxidase activity in Alzheimer disease patients.